Introducing at the American Diabetes Association 84th Scientific Sessions: The First FDA-Cleared Portable Handheld Device with Autonomous AI for On-the-Spot Diabetic Retinopathy Screening at Any Point of Care
Read more here.
Introducing at the American Diabetes Association 84th Scientific Sessions: The First FDA-Cleared Portable Handheld Device with Autonomous AI for On-the-Spot Diabetic Retinopathy Screening at Any Point of Care
Read more here.
![[PROOF in Entrepreneur] Disrupting Venture Capital: How PROOF VC Fund Aims To Invest Only In The “Hits”](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
